![Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections | Nature Communications Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-31838-8/MediaObjects/41467_2022_31838_Fig1_HTML.png)
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections | Nature Communications
![Milder disease with Omicron: is it the virus or the pre-existing immunity? | Nature Reviews Immunology Milder disease with Omicron: is it the virus or the pre-existing immunity? | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00678-4/MediaObjects/41577_2022_678_Fig1_HTML.png)
Milder disease with Omicron: is it the virus or the pre-existing immunity? | Nature Reviews Immunology
![Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission - The Lancet Regional Health – Europe Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/b105a03b-7543-4a15-b093-6bb4b40d9d3a/gr1_lrg.jpg)
Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission - The Lancet Regional Health – Europe
![IJERPH | Free Full-Text | Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant IJERPH | Free Full-Text | Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant](https://www.mdpi.com/ijerph/ijerph-19-06330/article_deploy/html/images/ijerph-19-06330-g001.png)
IJERPH | Free Full-Text | Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant
![Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study - The Lancet Healthy Longevity Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/6fbe3bfe-ece7-438c-be72-c98a86f910ee/gr1_lrg.jpg)
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study - The Lancet Healthy Longevity
![How contagious is Delta? How long are you infectious? Is it more deadly? A quick guide to the latest science - Health Check How contagious is Delta? How long are you infectious? Is it more deadly? A quick guide to the latest science - Health Check](https://i0.wp.com/images.theconversation.com/files/423460/original/file-20210928-21-19maks8.png?ssl=1)
How contagious is Delta? How long are you infectious? Is it more deadly? A quick guide to the latest science - Health Check
![Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities - eClinicalMedicine Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities - eClinicalMedicine](https://www.thelancet.com/cms/attachment/f64ccb44-1204-4bae-b947-11332c1eda64/gr1.jpg)
Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities - eClinicalMedicine
![Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study - eClinicalMedicine Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/a260c5f5-8e9c-449f-a91c-fb7caf88b74d/gr1.jpg)